153 related articles for article (PubMed ID: 12298121)
1. Antimicrobial treatment of community-acquired pneumonia in Hong Kong.
You JH; Lee VW; Au PS; Lee KK
Am J Health Syst Pharm; 2002 Sep; 59(18):1785-6. PubMed ID: 12298121
[No Abstract] [Full Text] [Related]
2. Journal of Managed Care Pharmacy. START (Stewardship Tactics for Antimicrobial Resistance Trends). Introduction.
Rodvold KA
J Manag Care Pharm; 2009 Mar; 15(2 Suppl):S3-4. PubMed ID: 19358369
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens.
Hoeffken G; Talan D; Larsen LS; Peloquin S; Choudhri SH; Haverstock D; Jackson P; Church D
Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):772-5. PubMed ID: 15605184
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effects of intravenous ciprofloxacin on community-acquired pneumonia with positive Immunocard Mycoplasma test results].
Okimoto N; Nanba F; Kibayashi T; Kishimoto M; Yamato K; Kurihara T; Honda Y; Osaki K; Asaoka N
Nihon Kokyuki Gakkai Zasshi; 2008 Feb; 46(2):92-5. PubMed ID: 18318249
[TBL] [Abstract][Full Text] [Related]
5. [Trends in the treatment of pneumonia].
Grassi V; Romanelli G
Recenti Prog Med; 1999; 90(7-8):373-9. PubMed ID: 10429515
[No Abstract] [Full Text] [Related]
6. [Hospital-acquired pneumonia].
Szilasi M
Orv Hetil; 2007 Feb; 148(5):229-30. PubMed ID: 17344144
[No Abstract] [Full Text] [Related]
7. [Severe pneumonia in the intensive care unit].
Welte T
Med Klin Intensivmed Notfmed; 2016 May; 111(4):279-89. PubMed ID: 27160261
[TBL] [Abstract][Full Text] [Related]
8. [The effect of intravenous ciprofloxacin for community acquired pneumonia in adults].
Fujita M; Ishibashi T; Hara N; Yoshida M; Yamada H;
Jpn J Antibiot; 2003 Aug; 56(4):289-93. PubMed ID: 14567253
[TBL] [Abstract][Full Text] [Related]
9. Oral levofloxacin in the treatment of community-acquired pneumonia.
Nicodemo AC; Lima Nicodemo E; Idrahim KY
Braz J Infect Dis; 2000 Apr; 4(2):61-6. PubMed ID: 10795070
[TBL] [Abstract][Full Text] [Related]
10. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.
DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
Trials; 2015 Aug; 16():355. PubMed ID: 26272324
[TBL] [Abstract][Full Text] [Related]
11. Empiric antimicrobial therapy of community-acquired pneumonia: clinical diagnosis versus procalcitonin levels.
Cunha BA
Scand J Infect Dis; 2009; 41(10):782-4. PubMed ID: 19681019
[No Abstract] [Full Text] [Related]
12. [Antibiotic therapy of bronchial infections. 2: Community acquired and nosocomial pneumonias].
Buchenroth M
MMW Fortschr Med; 1999 Dec; 141(49-50):48-50. PubMed ID: 10726149
[No Abstract] [Full Text] [Related]
13. Endocarditis diagnosed as multilobar, community acquired pneumonia.
Muntan CD; Haydel M
Emerg Med J; 2004 Mar; 21(2):244-5. PubMed ID: 14988364
[No Abstract] [Full Text] [Related]
14. Should nursing home-acquired pneumonia be treated as nosocomial pneumonia?
Ma HM; Wah JL; Woo J
J Am Med Dir Assoc; 2012 Oct; 13(8):727-31. PubMed ID: 22889729
[TBL] [Abstract][Full Text] [Related]
15. IV-to-oral switch therapy for community-acquired pneumonia requiring hospitalization: focus on gatifloxacin.
Pelly L
Adv Ther; 2002; 19(5):229-42. PubMed ID: 12539883
[TBL] [Abstract][Full Text] [Related]
16. [Update pneumonia 2012].
Pletz MW; Ewig S; Lange C; Welte T; Höffken G
Dtsch Med Wochenschr; 2012 Nov; 137(44):2265-80; quiz 2281-4. PubMed ID: 23093399
[TBL] [Abstract][Full Text] [Related]
17. Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia.
Mandell LA; Jones RN
Diagn Microbiol Infect Dis; 2002 Sep; 44(1):127-8. PubMed ID: 12376042
[No Abstract] [Full Text] [Related]
18. [Program of empirical antibacterial therapy of community-acquired pneumonia].
Suvorova MP; Iakovlev SV; Shakhova TV; Dvoretskiĭ LI
Antibiot Khimioter; 1998; 43(7):31-5. PubMed ID: 9727165
[TBL] [Abstract][Full Text] [Related]
19. [Uncomplicated community-acquired pneumonia. Under control in 3 treatment days].
MMW Fortschr Med; 2003 Jan; 145(3-4):58. PubMed ID: 12619240
[No Abstract] [Full Text] [Related]
20. De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia.
Yamana H; Matsui H; Tagami T; Hirashima J; Fushimi K; Yasunaga H
J Infect; 2016 Oct; 73(4):314-25. PubMed ID: 27394401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
